Potential Feature Exploration and Model Development Based on 18F-FDG PET/CT Images for Differentiating Benign and Malignant Lung Lesions
Overview
Authors
Affiliations
Purpose: The study is to explore potential features and develop classification models for distinguishing benign and malignant lung lesions based on CT-radiomics features and PET metabolic parameters extracted from PET/CT images.
Materials And Methods: A retrospective study was conducted in baseline 18 F-flurodeoxyglucose positron emission tomography/ computed tomography (18 F-FDG PET/CT) images of 135 patients. The dataset was utilized for feature extraction of CT-radiomics features and PET metabolic parameters based on volume of interest, then went through feature selection and model development with strategy of five-fold cross-validation. Specifically, model development used support vector machine, PET metabolic parameters selection used Akaike's information criterion, and CT-radiomics were reduced by the least absolute shrinkage and selection operator method then forward selection approach. The diagnostic performances of CT-radiomics, PET metabolic parameters and combination of both were illustrated by receiver operating characteristic (ROC) curves, and compared by Delong test. Five groups of selected PET metabolic parameters and CT-radiomics were counted, and potential features were found and analyzed with Mann-Whitney U test.
Results: The CT-radiomics, PET metabolic parameters, and combination of both among five subsets showed mean area under the curve (AUC) of 0.820 ± 0.053, 0.874 ± 0.081, and 0.887 ± 0.046, respectively. No significant differences in ROC among models were observed through pairwise comparison in each fold (P-value from 0.09 to 0.81, Delong test). The potential features were found to be SurfaceVolumeRatio and SUVpeak (P < 0.001 of both, U test).
Conclusion: The classification models developed by CT-radiomics features and PET metabolic parameters based on PET/CT images have substantial diagnostic capacity on lung lesions.
Liu H, Meng X, Wang G, Yao S, Wang Y, Wang R Ann Nucl Med. 2025; .
PMID: 40042775 DOI: 10.1007/s12149-025-02034-7.
Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT.
Yuan L, An L, Zhu Y, Duan C, Kong W, Jiang P Cancer Manag Res. 2024; 16:361-375.
PMID: 38699652 PMC: 11063459. DOI: 10.2147/CMAR.S451871.
Nakajo M, Jinguji M, Ito S, Tani A, Hirahara M, Yoshiura T Jpn J Radiol. 2023; 42(1):28-55.
PMID: 37526865 PMC: 10764437. DOI: 10.1007/s11604-023-01476-1.
Hu Q, Li K, Yang C, Wang Y, Huang R, Gu M Front Oncol. 2023; 13:1133164.
PMID: 36959810 PMC: 10028142. DOI: 10.3389/fonc.2023.1133164.
Tankyevych O, Trousset F, Latappy C, Berraho M, Dutilh J, Tasu J Cancers (Basel). 2022; 14(23).
PMID: 36497415 PMC: 9739232. DOI: 10.3390/cancers14235931.